Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masashi Maeda

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|September 15, 2004
Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pigAkira Moriguchi, Kayoko Mihara, Toshiaki Aoki, et al.
Journal of Neurotrauma|November 25, 2005
Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonistKayoko Mihara, Toshiaki Aoki, Akira Moriguchi, et al.
International Journal of Pharmaceutics|July 11, 2015
Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation modelRyo Kojima, Takatsune Yoshida, Hiroaki Tasaki, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 4, 2003
Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primatesYasuhisa Furuichi, Masashi Maeda, Akira Moriguchi, et al.
Brain Research|February 20, 2003
Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacyYasuhisa Furuichi, Kiyotaka Katsuta, Masashi Maeda, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 9, 2002
A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time windowMasashi Maeda, Yasuhisa Furuichi, Noriko Ueyama, et al.
International Immunopharmacology|November 5, 2022
Lit-LAMP-DNA-vaccine for shrimp allergy prevents anaphylactic symptoms in a murine modelKaori Kubo, Shinobu Takeda, Masao Uchida, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 29, 2005
FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activatorMasashi Maeda, Akira Moriguchi, Kayoko Mihara, et al.
Transplantation Proceedings|August 11, 2019
ASP1126, a Novel Sphingosine-1-Phosphate-Selective Agonist With a Favorable Safety Profile, Prolongs Allograft Survival in Rats and Nonhuman Primates in Combination With Tacrolimus With a Broad Safety Margin for BradycardiaAkira Okimoto, Rie Yamamoto, Jun Hirose, et al.
Frontiers in Robotics and AI|September 25, 2025
Encouraging classroom activities for children using avatar robots: a field trialMegumi Kawata, Masashi Maeda, Hirokazu Kumazaki, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|September 15, 2004
Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pigAkira Moriguchi, Kayoko Mihara, Toshiaki Aoki, et al.
Journal of Neurotrauma|November 25, 2005
Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonistKayoko Mihara, Toshiaki Aoki, Akira Moriguchi, et al.
International Journal of Pharmaceutics|July 11, 2015
Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation modelRyo Kojima, Takatsune Yoshida, Hiroaki Tasaki, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 4, 2003
Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primatesYasuhisa Furuichi, Masashi Maeda, Akira Moriguchi, et al.
Brain Research|February 20, 2003
Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacyYasuhisa Furuichi, Kiyotaka Katsuta, Masashi Maeda, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 9, 2002
A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time windowMasashi Maeda, Yasuhisa Furuichi, Noriko Ueyama, et al.
International Immunopharmacology|November 5, 2022
Lit-LAMP-DNA-vaccine for shrimp allergy prevents anaphylactic symptoms in a murine modelKaori Kubo, Shinobu Takeda, Masao Uchida, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 29, 2005
FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activatorMasashi Maeda, Akira Moriguchi, Kayoko Mihara, et al.
Transplantation Proceedings|August 11, 2019
ASP1126, a Novel Sphingosine-1-Phosphate-Selective Agonist With a Favorable Safety Profile, Prolongs Allograft Survival in Rats and Nonhuman Primates in Combination With Tacrolimus With a Broad Safety Margin for BradycardiaAkira Okimoto, Rie Yamamoto, Jun Hirose, et al.
Frontiers in Robotics and AI|September 25, 2025
Encouraging classroom activities for children using avatar robots: a field trialMegumi Kawata, Masashi Maeda, Hirokazu Kumazaki, et al.
Pageof 4